Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för trovafloxacin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2014-02-13

Trovafloxacin potentiation of lipopolysaccharide-induced tumor necrosis factor release from RAW 264.7 cells requires extracellular signal-regulated kinase and c-Jun N-Terminal Kinase.

Poulsen KL, Albee RP, Ganey PE, Roth RA.

J Pharmacol Exp Ther · research-article; journal article; research support, n.i.h., extramural · DOI 10.1124/jpet.113.211276

Bibliografisk träff 2013-10-04

Molecular mechanisms of hepatocellular apoptosis induced by trovafloxacin-tumor necrosis factor-alpha interaction.

Beggs KM, Fullerton AM, Miyakawa K, Ganey PE, Roth RA.

Toxicol Sci · research-article; journal article; research support, n.i.h., extramural · DOI 10.1093/toxsci/kft226

Bibliografisk träff 2013-05-04

First liquid chromatography method for the simultaneous determination of levofloxacin, pazufloxacin, gatifloxacin, moxifloxacin and trovafloxacin in human plasma.

Sousa J, Alves G, Campos G, Fortuna A, Falcão A.

J Chromatogr B Analyt Technol Biomed Life Sci · research support, non-u.s. gov't; journal article · DOI 10.1016/j.jchromb.2013.04.036

Bibliografisk träff 2012-01-15

Determination of trovafloxacin and marbofloxacin in sheep plasma samples by HPLC using UV detection.

Mahmood AH, Medley GA, Grice JE, Liu X, Roberts MS.

J Pharm Biomed Anal · research support, non-u.s. gov't; validation study; journal article · DOI 10.1016/j.jpba.2012.01.007

Bibliografisk träff 2010-11-18

Comparison of TNFα to lipopolysaccharide as an inflammagen to characterize the idiosyncratic hepatotoxicity potential of drugs: Trovafloxacin as an example.

Liguori MJ, Ditewig AC, Maddox JF, Luyendyk JP, Lehman-McKeeman LD, Nelson DM, Bhaskaran VM, Waring JF, Ganey PE, Roth RA, Blomme EA.

Int J Mol Sci · comparative study; research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.3390/ijms11114697

Bibliografisk träff 2010-07-23

Trovafloxacin, a fluoroquinolone antibiotic with hepatotoxic potential, causes mitochondrial peroxynitrite stress in a mouse model of underlying mitochondrial dysfunction.

Hsiao CJ, Younis H, Boelsterli UA.

Chem Biol Interact · research support, non-u.s. gov't; journal article · DOI 10.1016/j.cbi.2010.07.017

Bibliografisk träff 2010-06-10

Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity.

Shaw PJ, Ganey PE, Roth RA.

Toxicol Sci · review-article; review; journal article; research support, n.i.h., extramural · DOI 10.1093/toxsci/kfq168

Bibliografisk träff 2010-05-11

Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis for experimental murine melioidosis.

Kenny DJ, Sefton AM, Brooks TJ, Laws TR, Simpson AJ, Atkins HS.

Int J Antimicrob Agents · research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijantimicag.2010.03.019

Bibliografisk träff 2009-12-21

Evaluation of azithromycin, trovafloxacin and grepafloxacin as prophylaxis against experimental murine Brucella melitensis infection.

Atkins HS, Spencer S, Brew SD, Jenner DC, Sefton AM, MacMillan AP, Brooks TJ, Simpson AJ.

Int J Antimicrob Agents · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1016/j.ijantimicag.2009.10.003